TP53 and idiopathic pulmonary fibrosis: Mechanistically, this is consistent with the persistent injury and oxidative stress present in IPF lungs, which induce CDKN2A expression, activate the p16 and p53 pathways, and drive alveolar epithelial cell cycle arrest and the establishment of a SASP (26).